Midwest Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$484K Buy
11,079
+1,116
+11% +$51.7K 0.01% 467
2026
Q2
$425K Buy
9,963
+114
+1% +$6.19K ﹤0.01% 478
2026
Q1
$618K Sell
9,849
-266
-3% -$21.3K 0.01% 406
2025
Q4
$964K Sell
10,115
-2
-0% -$196 0.01% 343
2025
Q3
$988K Buy
10,117
+1,568
+18% +$162K 0.01% 347
2025
Q2
$918K Buy
+8,549
New +$865K 0.01% 351

Other funds holding BSX

Midwest Trust's BSX Position: Q3 2026 in Review

Midwest Trust increased its Boston Scientific (BSX) stake by 11% in Q3 2026, buying an estimated $51.7K and bringing the position to 11,079 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #467.

Midwest Trust first reported a position in BSX in Q2 2025 and has held it in 6 quarters since. The position peaked at $988K in Q3 2025. 572 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Midwest Trust held 11,079 shares of Boston Scientific worth $484K as of Q3 2026.
  • Midwest Trust bought 1,116 Boston Scientific shares in Q3 2026, an estimated $51.7K.
  • Boston Scientific made up 0.01% of Midwest Trust's portfolio in Q3 2026, its #467 holding.
  • Midwest Trust first reported a position in Boston Scientific in Q2 2025 and has held it in 6 quarters since.
  • Midwest Trust's Boston Scientific position peaked at $988K in Q3 2025.
  • 572 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.